Wei Chen
Impact in
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
- Hepatology top 2%
- Liver physiology and pathology
Papers in
- Hepatology 33
- Liver physiology and pathology 24
-
- Peroxisome Proliferator-Activated Receptors 12
- Kruppel-like factors research 9
- Co-authors
- Bruce R. Blazar (3 shared papers)David H. Munn (2 shared papers)Xueqing Liang (2 shared papers)Hong Jun You (21 shared papers)Chuan Qin (6 shared papers)Aiting Yang (16 shared papers)Jidong Jia (7 shared papers)Hui Han (15 shared papers)
- Journals
- Hepatology Communications (6 papers)PLoS ONE (6 papers)Scientific Reports (6 papers)Frontiers in Pharmacology (5 papers)Hepatology (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Wei Chen
315 papers receiving 8.6k citations
Wei Chen's Hit Papers
Peers
Comparison fields: 5 of 191
- Biological Psychiatry 378
- Hepatology 558
- Cell Biology 1.0k
- Cancer Research 755
- Molecular Biology 3.3k
Countries citing papers authored by Wei Chen
This map shows the geographic impact of Wei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Chen more than expected).
Fields of papers citing papers by Wei Chen
This network shows the impact of papers produced by Wei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Chen. The network helps show where Wei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 336 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 395 | |
| 2 | 2017 | 393 | |
| 3 | 2007 | 363 | |
| 4 | 2013 | 302 | |
| 5 | 2011 | 270 | |
| 6 | 2001 | 256 | |
| 7 | 2021 | 221 | |
| 8 | 2020 | 214 | |
| 9 | 2006 | 170 | |
| 10 | 2015 | 167 | |
| 11 | 2020 | 159 | |
| 12 | Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial Hit paper breakdown → | 2023 | 142 |
| 13 | 2021 | 118 | |
| 14 | Macrophage-derived Osteopontin (SPP1) Protects From Nonalcoholic Steatohepatitis Hit paper breakdown → | 2023 | 107 |
| 15 | 2017 | 100 | |
| 16 | 1999 | 99 | |
| 17 | 2015 | 92 | |
| 18 | 2019 | 91 | |
| 19 | 2016 | 90 | |
| 20 | 2013 | 85 |
About Wei Chen
Wei Chen is a scholar working on Hepatology, Molecular Biology, Epidemiology, Cell Biology and Cardiology and Cardiovascular Medicine, having authored 336 papers that have together received 8.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (24 papers), Liver physiology and pathology (24 papers), Viral Infections and Immunology Research (14 papers), Peroxisome Proliferator-Activated Receptors (12 papers), MicroRNA in disease regulation (12 papers), Kruppel-like factors research (9 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Biological Psychiatry (378 citations), Hepatology (558 citations), Cell Biology (1.0k citations), Cancer Research (755 citations) and Molecular Biology (3.3k citations). Wei Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Bruce R. Blazar, David H. Munn, Xueqing Liang, Hong Jun You, Chuan Qin, Aiting Yang, Jidong Jia, Hui Han, Kemper E. Lewis and Dipti Athavale. Their work appears in journals such as Hepatology Communications, PLoS ONE, Scientific Reports, Frontiers in Pharmacology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.